Cardinal Strategic Wealth Guidance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$454K Sell
494
-67
-12% -$67.9K 0.12% 38
2025
Q4
$603K Hold
561
0.16% 31
2025
Q3
$428K Sell
561
-50
-8% -$37.2K 0.12% 39
2025
Q2
$476K Sell
611
-29
-5% -$22.5K 0.14% 36
2025
Q1
$529K Hold
640
0.17% 35
2024
Q4
$494K Hold
640
0.16% 38
2024
Q3
$567K Sell
640
-6
-0.9% -$5.39K 0.19% 34
2024
Q2
$585K Sell
646
-105
-14% -$84K 0.21% 33
2024
Q1
$584K Sell
751
-92
-11% -$65.5K 0.22% 32
2023
Q4
$491K Hold
843
0.2% 41
2023
Q3
$453K Hold
843
0.21% 41
2023
Q2
$395K Buy
843
+35
+4% +$14.7K 0.18% 43
2023
Q1
$277K Sell
808
-7
-0.9% -$2.36K 0.13% 49
2022
Q4
$298K Sell
815
-40
-5% -$14.2K 0.14% 58
2022
Q3
$276K Sell
855
-12
-1% -$3.8K 0.15% 51
2022
Q2
$281K Sell
867
-35
-4% -$10.5K 0.14% 53
2022
Q1
$258K Sell
902
-50
-5% -$12.9K 0.12% 60
2021
Q4
$263K Hold
952
0.12% 63
2021
Q3
$220K Hold
952
0.12% 66
2021
Q2
$219K Buy
+952
New +$191K 0.12% 64

Other funds holding LLY

Cardinal Strategic Wealth Guidance's LLY Position: Q1 2026 in Review

Cardinal Strategic Wealth Guidance reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $67.9K and leaving 494 shares worth $454K. The position accounts for 0.12% of the portfolio, ranked #38.

Cardinal Strategic Wealth Guidance first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $603K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cardinal Strategic Wealth Guidance held 494 shares of Eli Lilly worth $454K as of Q1 2026.
  • Cardinal Strategic Wealth Guidance sold 67 Eli Lilly shares in Q1 2026, an estimated $67.9K.
  • Eli Lilly made up 0.12% of Cardinal Strategic Wealth Guidance's portfolio in Q1 2026, its #38 holding.
  • Cardinal Strategic Wealth Guidance first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
  • Cardinal Strategic Wealth Guidance's Eli Lilly position peaked at $603K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cardinal Strategic Wealth Guidance's 13F filing for Q1 2026, filed 20 Apr 2026.